These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2468467)

  • 21. Immunotherapy for multiple sclerosis: the curious case of interferon beta.
    Stüve O; Ransohoff RM
    Arch Neurol; 2009 Oct; 66(10):1193-4. PubMed ID: 19822773
    [No Abstract]   [Full Text] [Related]  

  • 22. Early multiple sclerosis: to treat or not to treat?
    Roach ES
    Arch Neurol; 2006 Apr; 63(4):619. PubMed ID: 16606782
    [No Abstract]   [Full Text] [Related]  

  • 23. New treatments for multiple sclerosis.
    Poirier J
    Axone; 1999 Mar; 20(3):78-9. PubMed ID: 10401269
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of MS symptoms. Here also are guidelines necessary].
    Henze T; Toyka KV
    Nervenarzt; 2004 Aug; 75 Suppl 1():S1. PubMed ID: 15480525
    [No Abstract]   [Full Text] [Related]  

  • 25. [Multiple sclerosis].
    Itoyama Y
    No To Shinkei; 2000 Dec; 52(12):1051-5. PubMed ID: 11193536
    [No Abstract]   [Full Text] [Related]  

  • 26. Multiple sclerosis. Treatment is shifting.
    Mayo Clin Health Lett; 2003 Jan; 21(1):6. PubMed ID: 12619619
    [No Abstract]   [Full Text] [Related]  

  • 27. Reason for hope: the advent of disease-modifying therapies in multiple sclerosis.
    O'Connor PW
    CMAJ; 2000 Jan; 162(1):83-4. PubMed ID: 11216206
    [No Abstract]   [Full Text] [Related]  

  • 28. Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary.
    Lopez-Diego RS; Weiner HL
    Nat Rev Drug Discov; 2008 Nov; 7(11):909-25. PubMed ID: 18974749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From etiology and pathogenesis to therapy of multiple sclerosis.
    Cazzullo CL
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):622-33. PubMed ID: 580220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New treatments for multiple sclerosis.
    Hutchinson M
    Ir Med J; 1996; 89(2):44. PubMed ID: 8682623
    [No Abstract]   [Full Text] [Related]  

  • 31. The challenge of managing patients with multiple sclerosis.
    MacLean R
    Nurs Times; 2004 Jan 27-Feb 2; 100(4):42-4. PubMed ID: 14974264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment and prevention of myelin disorders: multiple sclerosis.
    Abramsky O
    Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():489-92. PubMed ID: 6326915
    [No Abstract]   [Full Text] [Related]  

  • 33. Current methods of therapy in multiple sclerosis.
    Sibley WA
    Mod Treat; 1970 Sep; 7(5):918-29. PubMed ID: 4326377
    [No Abstract]   [Full Text] [Related]  

  • 34. Disease-modifying drugs for the early treatment of multiple sclerosis.
    Flachenecker P
    Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Aspects of immunosuppressive therapy of multiple sclerosis].
    Fischer W
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():23-6. PubMed ID: 829627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Not every patient with multiple sclerosis should be treated at time of diagnosis.
    Pittock SJ; Weinshenker BG; Noseworthy JH; Lucchinetti CF; Keegan M; Wingerchuk DM; Carter J; Shuster E; Rodriguez M
    Arch Neurol; 2006 Apr; 63(4):611-4. PubMed ID: 16606780
    [No Abstract]   [Full Text] [Related]  

  • 37. [New therapeutic possibilities for disseminated sclerosis?].
    Wanscher B; Sørensen PS
    Ugeskr Laeger; 1994 Oct; 156(43):6353-8. PubMed ID: 7810008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensive immunosuppression in multiple sclerosis.
    Zaffaroni M; Ghezzi A; Comi G
    Neurol Sci; 2006 Mar; 27 Suppl 1():S13-7. PubMed ID: 16708175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multiple sclerosis--what should be done?].
    Kesselring J
    Ther Umsch; 1993 Nov; 50(11):766-70. PubMed ID: 7514811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The BCTRIMS Expanded Consensus on treatment of multiple sclerosis: I. The evidences for the use of immunosuppressive agents, plasma exchange and autologous hematopoietic stem cell transplantation].
    Callegaro D; Lana-Peixoto MA; Moreira MA; Marchiori PE; Bacheschi LA; Arruda WO; Campos GB; Lino AM; Melo AS; Rocha FC; Ferreira ML; Ataide L; Maciel DR;
    Arq Neuropsiquiatr; 2002 Sep; 60(3-B):869-74. PubMed ID: 12364965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.